Morning Digest | Government forms panel to look into MGNREGA’s efficacy; States ask Centre to curb its cess habit, and more
Here’s a select list of stories to read before you start your day Source link
efficacy
Bavarian Nordic COVID booster shot shows efficacy 6-months after vaccination in trial
SilverV Bavarian Nordic (OTCPK:BVNRY) (OTCPK:BVNKF) (BAVN) said its COVID-19 booster vaccine ABNCoV2 showed durable antibody response six months after vaccination in a phase 2 trial. The company noted that previously reported results from the study showed, 100ug ABNCoV2 in 103 seropositive people was able to show a strong boosting effect, increasing the existing levels of … Read more
GSK RSV vaccine for older adults shows 94.1% efficacy in severe disease in phase 3 trial
13threephotography/iStock Editorial via Getty Images GSK (NYSE:GSK) said its respiratory syncytial virus (RSV) vaccine candidate showed an overall vaccine efficacy of 82.6% against RSV lower respiratory tract disease (RSV-LRTD) in adults aged 60 years and above, meeting the main goal of a phase 3 trial. The British pharma giant reported more data from the late-stage … Read more
Sanofi/Regeneron Dupixent shows efficacy in kids with esophagus inflammation in trial
JHVEPhoto Sanofi (NASDAQ:SNY) and Regeneron Pharmaceuticals (NASDAQ:REGN) said their medicine Dupixent showed positive results in a phase 3 trial to treat children aged one to 11 years with active eosinophilic esophagitis (EoE). EoE is a chronic and progressive inflammatory disease which damages the esophagus and can make it difficult to swallow. Dupixent led to significant … Read more
SAB Bio rises as H1N1 influenza and COVID-19 treatments show efficacy in trial
SAB Bio rises as H1N1 influenza and COVID-19 treatments show efficacy in trial Source link
Live Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope’s Efficacy Against SARS-CoV-2 Variants Including BA.5
This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Breadcrumb Trail Links PMN Press Releases Business Wire News Releases Author of the article: Article content VICTORIA, British … Read more
Efficacy of Pfizer’s Covid-19 pill questioned — RT World News
An Israeli study has indicated the medication is of little measurable benefit to patients in the 40-65 age bracket A Covid-19 pill lauded by the World Health Organization (WHO) may be of little or no benefit to patients aged between 40 and 65, a new study by Israeli researchers has suggested. The medication, made by … Read more
US media questions Russia sanctions’ efficacy — RT World News
The punitive measures against Moscow didn’t cause the collapse Western leaders had hoped for, the Washington post has said Six months since unprecedented sanctions were slapped on Russia, the country’s economy has still not shown any signs of the collapse that Western leaders had initially expected, a leading US newspaper has assessed. An editorial published … Read more